Kronos Bio Implements Workforce Reduction to Extend Financial Runway
Company Announcements

Kronos Bio Implements Workforce Reduction to Extend Financial Runway

Kronos Bio (KRON) just unveiled an update.

Kronos Bio, Inc. is set to reduce its workforce by 21% as a measure to reallocate resources and manage costs more effectively. This cut is expected to be finalized swiftly by March 7, 2024, and will result in approximately $0.5 million in severance costs and an additional $0.1 million for health insurance reimbursements. This decision is part of a broader strategy that aims to extend the company’s financial runway, ensuring its operations are funded well into the second half of 2026.

Find detailed analytics on KRON stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyKronos Bio files $250M mixed securities shelf
TheFlyKronos Bio to present data at ASH annual meeting on p300 KAT inhibitor program
Brian AndersonKRON Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App